RAPGEF5 and intrahepatic cholangiocarcinoma: To investigate the role of Circ-RAPGEF5 in the progression of ICC in a model that closely mimics the clinical situation, we selected a patient-derived tumor xenograft (PDX) model for the in vivo experiments.